Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06360380 · ClinicalTrials.gov registry record · NA
Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
A NA study of Chronic Heart Failure and CKD Stage 3, sponsored by AquaPass Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 4
- Study locations
NCT06360380 is a NA study of Chronic Heart Failure and CKD Stage 3 that is actively recruiting participants, run by AquaPass Medical. The registered enrollment target is 40 participants, below the 419-participant average among 12 other Chronic Heart Failure trials with a reported enrollment target (90% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT06360380, a NA study of Chronic Heart Failure and CKD Stage 3, is actively recruiting participants, sponsored by AquaPass Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 4
- Study locations
Study Summary
The REFORM-HF study aims to test a new technology, AquaPass, designed to assist patients experiencing symptoms of fluid overload due to Heart Failure. Patients will wear a lightweight suit that helps remove excess fluids through their sweat. The investigators want to see if the AquaPass system can remove an additional 500mL of fluids during treatment, alongside patients' regular medications like diuretics. Participants will select if to be treated at their home or in the outpatient clinic.
Conditions Studied
Interventions
- DEVICE AquaPass System
Study Locations (4)
Other
- Rambam Medical Campus - Haifa
- Rabin Medical Center - Petah Tikva
New York
- Rochester Regional Health - Rochester
North Carolina
- Cone Health Advanced Heart Failure Clinic at Moses Cone - Greensboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-09-05 |
| Est. Completion | 2025-01-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06360380
The ClinicalTrials.gov registry entry for NCT06360380 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 419-participant average among 12 other Chronic Heart Failure trials with a reported enrollment target (90% lower). The listed sponsor is AquaPass Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which AquaPass System is the first listed.
NCT06360380 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Other, New York, North Carolina.
Frequently Asked Questions
What is clinical trial NCT06360380 about?
NCT06360380 is a clinical study titled "Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System". The REFORM-HF study aims to test a new technology, AquaPass, designed to assist patients experiencing symptoms of fluid overload due to Heart Failure. Patients will wear a lightweight suit that helps remove excess fluids through their sweat. The investigators want to see if the AquaPass system can...
What is the current status of trial NCT06360380?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-09-05. Estimated completion is 2025-01-29.
What conditions does trial NCT06360380 study?
This clinical trial studies the following conditions: Chronic Heart Failure, CKD Stage 3.
What interventions are being tested in trial NCT06360380?
The interventions under investigation include: AquaPass System (DEVICE).
Who is sponsoring clinical trial NCT06360380?
This trial is sponsored by AquaPass Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06360380 being conducted?
This trial has 4 study locations across New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
RECRUITING · NA
-
Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment
RECRUITING · NA
-
The HEARTFELT Study
RECRUITING · NA
-
Cost and Shared Decision-Making for Heart Failure
COMPLETED · NA
-
Telehealth Management in HF Disparity Patients
COMPLETED · NA
-
Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.